"Consumers and health care professionals will soon find updated labeling for extended-release and long-acting opioid pain relievers to help ensure their safe and appropriate use.
In addition to requiring new labeling on these prescript"...
Read the Synalgos DC (aspirin, caffeine, and dihydrocodeine bitartrate capsules, usp) Side Effects Center for a complete guide to possible side effects
The CNS-depressant effects of Synalgos-DC may be additive with that of other CNS depressants. See “WARNINGS.” Aspirin may enhance the effects of anticoagulants and inhibit the uricosuric effects of uricosuric agents.
Clinical studies of Synalgos-DC did not include sufficient numbers of subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects.
In general, dose selection for an elderly patient should be cautious, starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
Last reviewed on RxList: 6/4/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional Synalgos DC Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Chronic Pain/Back Pain
Find tips and advances in treatment.